To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy.
By clicking on the Accept & Close button, you provide your explicit consent to the processing of your data to achieve the above goal.
You can withdraw your consent using the method specified in the Privacy Policy.
Accept & Close
Sputnik International
Highlights
In Delhi, the COVID-19 vaccine rollout will span across 11 districts at 81 centres.
As many as six central government hospitals - AIIMS, Safdarjung Hospital, RML Hospital, Kalawati Saran Children Hospital and two ESI hospitals - are part of the vaccine drive.
Private facilities Max Hospital, Fortis Hospital, Apollo Hospital and Sir Ganga Ram Hospital are also part of the country-wide vaccine rollout.
New Delhi: As the nation-wide coronavirus
COVID-19 vaccination drive kicked-off on January 16, 2021, the All India Medical Institute (AIIMS) director Dr Randeep Guleria received a dose of the vaccine at the hospital in the presence of Union Health Minister Harsh Vardhan.
Updated Jan 16, 2021 | 17:23 IST
The Resident Doctors Association (RDA) of the Ram Manohar Lohia Hospital rejected Covaxin and requested the medical superintendent to vaccinate them with Oxford COVID-19 vaccine Covishield. Oxford COVID-19 vaccine Covishield
Key Highlights Covaxin manufactured by Bharat Biotech is being preferred in our hospital over Covishield manufactured by Serum Institute The residents are a bit apprehensive about the lack of complete trial in case of Covaxin We request you to vaccinate us with Covishield which has completed all stages of trial before its roll-out
New Delhi: Rejecting Covaxin due to ‘lack of complete trial’, resident doctors of Ram Manohar Lohia Hospital requested the medical superintendent to vaccinate them with Oxford COVID-19 vaccine Covishield.
Dr Vikas Dogra, one of the 3,000 healthcare workers who received the first jab of Covid vaccine Covaxin nationwide, told IANS on Saturday that the opaqueness in the data of clinical trials for Covaxin, manufactured by Bharat Biotech, has led .
The Resident Doctors Association of the Ram Manohar Lohia Hospital in New Delhi on Saturday requested the medical superintendent to vaccinate them with Oxford COVID-19 vaccine Covishield